Yu J - Search Results

1

Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation.

Wei Y, Wei C, Chen L, Liu N, Ou Q, Yin JC, Pang J, Fang Z, Wu X, Wang X, Mu D, Shao Y, Yu J, Yuan S. Wei Y, et al. Among authors: yu j. Cancer Res Treat. 2022 Oct;54(4):1209-1218. doi: 10.4143/crt.2021.963. Epub 2022 Jan 17. Cancer Res Treat. 2022. PMID: 35038823 Free PMC article.

2

DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma.

Yu JM, Zhang H, Wang SQ, Miao HQ, Yang LH, Chen YT, Tian GD. Yu JM, et al. Cancer. 1991 Jul 1;68(1):76-8. doi: 10.1002/1097-0142(19910701)68:1<76::aid-cncr2820680115>3.0.co;2-l. Cancer. 1991. PMID: 2049757

3

[Research and advancement of image-guided radiotherapy].

Yu JM, Yuan SH. Yu JM, et al. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):81-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16750004 Review. Chinese. No abstract available.

4

Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.

Yuan S, Yu Y, Chao KS, Fu Z, Yin Y, Liu T, Chen S, Yang X, Yang G, Guo H, Yu J. Yuan S, et al. Among authors: yu y, yu j. J Nucl Med. 2006 Aug;47(8):1255-9. J Nucl Med. 2006. PMID: 16883002 Free article. Clinical Trial.

5

Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.

Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, Zhong W, Yu Y, Wang J, Sun X, Yang G, Wang Y. Yuan S, et al. Among authors: yu y, yu j. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):727-34. doi: 10.1016/j.ijrobp.2006.08.057. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293231

6

A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.

Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, Li J, Liu X, Wang R, Li B, Kong L, Yin Y. Yuan S, et al. Among authors: yu y, yu j. Am J Clin Oncol. 2007 Jun;30(3):239-44. doi: 10.1097/01.coc.0000256691.27796.24. Am J Clin Oncol. 2007. PMID: 17551299 Clinical Trial.

7

[Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].

Mu DB, Wang SP, Yang WF, Fu Z, Chen XX, Sun XR, Yu JM. Mu DB, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):30-3. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17575690 Chinese.

8

Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression.

Wang H, Yu J, Yang G, Song X, Sun X, Zhao S, Mu D. Wang H, et al. Among authors: yu j. Cancer Sci. 2007 Sep;98(9):1413-6. doi: 10.1111/j.1349-7006.2007.00562.x. Epub 2007 Jul 11. Cancer Sci. 2007. PMID: 17627611 Free PMC article.

9

Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.

Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J. Guo H, et al. Among authors: yu j. J Nucl Med. 2007 Aug;48(8):1251-8. doi: 10.2967/jnumed.106.036509. Epub 2007 Jul 13. J Nucl Med. 2007. PMID: 17631554 Free article.

10

[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].

Yuan SH, Yu JM, Yu YH, Fu Z, Guo HB, Liu TH, Yang XH, Yang GR, Li WW. Yuan SH, et al. Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):221-4. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17649642 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,049 results

Search Page

Filters